HIGHLIGHTS
- who: Hironori Nakagami and collaborators from the Department of Health Development and Medicine, Graduate School of Medicine, Osaka University, Yamada-oka, Suita, Osaka, Japan have published the research work: Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults, in the Journal: Vaccines 2022, 10, 1427. of /2022/
- what: For the high-dose group, two investigational devices were filled with 0.1 mL of the study drug, and one device was used per site for intradermal inoculation at two . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.